Funds and ETFs Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 10:08:32 2024-05-13 EDT 5-day change 1st Jan Change
74.68 CHF +1.47% Intraday chart for Alcon Inc. +3.30% +13.56%

ETFs positioned on Alcon Inc.

Name Weight AuM 1st Jan change Investor Rating
3.96% 121 M€ -.--%
1.24% 17 M€ +6.60% -
1.04% 48 M€ +9.09%
0.49% 6 M€ -.--% -
0.41% 727 M€ +8.40%
0.36% 25 M€ +4.09% -
0.34% 6 M€ -.--%
0.30% 32 M€ +7.24% -
0.24% 7 M€ +4.81% -
0.23% 10 M€ -3.35% -
0.23% 36 M€ +3.08% -
0.12% 242 M€ +8.78%
0.11% 284 M€ -.--%
0.11% 206 M€ -.--%
0.10% 23 M€ -.--% -
0.10% 786 M€ -.--%
0.07% 1,166 M€ +0.26%
0.07% 607 M€ +0.05%
0.07% 283 M€ +19.00%
0.05% 0 M€ 0.00% -
0.05% 391 M€ +8.67% -
0.04% 7 M€ +0.11% -
0.04% 34 M€ +8.24% -
0.04% 45 M€ 0.00% -
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
81.17 USD
Average target price
93.1 USD
Spread / Average Target
+14.70%
Consensus
  1. Stock Market
  2. Equities
  3. ALC Stock
  4. Funds and ETFs Alcon Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW